Document Detail

American Radium Society 92nd annual meeting.
MedLine Citation:
PMID:  20735305     Owner:  NLM     Status:  In-Process    
We provide a summary of the 92nd Annual Meeting of the American Radium Society (ARS), the oldest organization devoted to the study of cancer. This May 2010 meeting included a postgraduate course/contouring laboratory, seven scientific sessions, two keynote lectures, one Janeway lecture, four Panel presentations, one debate, one satellite symposium and 107 poster presentations - details of each of these activities are provided. All of these academic activities revolved around the major meeting theme of 'Improved Outcomes Through Judicious Applications of Advanced Technology'.
Ashesh B Jani; Quynh-Thu Le; Jeff J Michalski; Raymond Sawaya; Lynn D Wilson
Related Documents :
24017545 - The in-situ analysis of precipitates in some mg-rare earth alloys.
25145025 - Dumping and illegal transport of hazardous waste, danger of modern society.
16017755 - Honolulu invites you to mla 79.
20019125 - Introduction to the year in basic science series...2009.
21951635 - The ethical complexities of online organ solicitation via donor-patient websites: avoid...
18406255 - Mineralocorticoid madness.
Publication Detail:
Type:  Congresses    
Journal Detail:
Title:  Expert review of anticancer therapy     Volume:  10     ISSN:  1744-8328     ISO Abbreviation:  Expert Rev Anticancer Ther     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101123358     Medline TA:  Expert Rev Anticancer Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1183-5     Citation Subset:  IM    
Department of Radiation Oncology, Emory University, 1365 Clifton Road, NE, Suite A1300, Atlanta, GA 30322, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lapatinib and breast cancer: current indications and outlook for the future.
Next Document:  Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks.